Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Current Leases of $1.6 million for Q1 2026, down 90.18% on a QoQ basis from $16.5 million in Q4 2025, and down 88.82% year-over-year from $14.5 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Current Leases (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Current Leases history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Current Leases fell 88.82% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 88.82% YoY) and the FY2025 annual result came in at $16.5 million, up 1510.43% from the prior year.
- Current Leases was $1.6 million for Q1 2026 at Aurinia Pharmaceuticals, down from $16.5 million in the prior quarter.
- Across five years, Current Leases topped out at $16.5 million in Q4 2025 and bottomed at $918000.0 in Q3 2022.
- A 5-year average of $5.4 million and a median of $1.0 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases plunged 92.98% — and 2025, when it jumped 1510.43%.
- Aurinia Pharmaceuticals' Current Leases stood at $918000.0 in 2022, then soared by 1491.39% to $14.6 million in 2023, then tumbled by 92.98% to $1.0 million in 2024, then soared by 1510.43% to $16.5 million in 2025, then tumbled by 90.18% to $1.6 million in 2026.
- Business Quant data shows AUPH's Current Leases at $1.6 million in Q1 2026, $16.5 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Aurinia Pharmaceuticals | 2.02 Bn | 1.64 Bn | 71.20 Mn | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | 16.52 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 14.51 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 14.93 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 13.72 Mn |
| Dec 31, 2023 | 14.61 Mn |
| Sep 30, 2023 | 980,000.00 |
| Jun 30, 2023 | 954,000.00 |
| Mar 31, 2023 | 945,000.00 |
| Sep 30, 2022 | 918,000.00 |
| Jun 30, 2022 | 953,000.00 |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.11 Mn |
| Mar 31, 2021 | 1.08 Mn |